Anixa Biosciences (ANIX) Proxy Filing summary

Executive summary

• The annual meeting will be held virtually on March 10, 2026, to elect directors, approve executive compensation on an advisory basis, and ratify the independent auditor for fiscal 2026.

• Stockholders of record as of January 13, 2026, are entitled to vote, with each share of common stock carrying one vote.

• Proxy materials are available online, and stockholders are encouraged to vote via internet, phone, mail, or at the virtual meeting.

Voting matters and shareholder proposals

• Four director nominees are up for election for a one-year term: Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr.

• Advisory approval of named executive officer compensation (say-on-pay) is on the agenda.

• Ratification of Haskell & White LLP as independent auditor for fiscal year ending October 31, 2026, is proposed.

• Board unanimously recommends voting FOR all proposals.

Board of directors and corporate governance

• Board consists of four directors, with three meeting the SEC definition of independence.

• Separate audit, compensation, and nominating/corporate governance committees are in place, each composed of independent directors.

• Lead independent director role is held by Mr. Titterton; board structure is reviewed as needed.

• Directors attended all board and committee meetings in fiscal 2025.

• Code of ethics applies to senior officers and is available on the company website.